Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Collplant Holdings (CLGN)
NASDAQ:CLGN
RESEARCH TOOLSreports
Holding CLGN?
Track your performance easily
Earnings Data
Report Date
Apr 02, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-$0.13Last Year’s EPS
-$0.37Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 27, 2024
|% Change Since: -20.05%
|Next Earnings Date:Apr 02, 2025
Earnings Call Sentiment|Neutral
The call presented significant advancements in the regenerative breast implant program and ongoing collaborations, particularly with AbbVie, indicating strong potential for future growth. However, financial performance showed a substantial decline in revenue and increased net losses, highlighting financial challenges.Company Guidance
During CollPlant Biotechnologies' Q3 2024 earnings call, the company provided detailed guidance on its ongoing programs and financial performance. The company is progressing with its preclinical studies on regenerative breast implants, which feature proprietary rhCollagen-based bioinks printed with Stratasys' 3D printer. These implants are designed for controlled degradation and enhanced durability, showing promising results like significant vascularization and native tissue ingrowth. Financially, CollPlant reported Q3 GAAP revenues of $4,000, a decrease from $43,000 in Q3 2023, primarily due to planned supply schedules with its largest customer. Non-GAAP operating expenses for Q3 2024 were $3.8 million, slightly down from $3.9 million the previous year, with cash and cash equivalents standing at $15.4 million as of September 30, 2024. The company aims to secure additional partnerships in 2025 to support its developments in the dermal filler program with AbbVie and other initiatives.Advancement in Regenerative Breast Implant Program
Progress in the preclinical study of breast implants with positive results showing significant implant vascularization and rapid ingrowth of native tissue, which are critical for effective integration with host tissue.
Collaboration with AbbVie
Ongoing collaboration with AbbVie focused on developing a dermal and soft tissue filler product, with the filler market valued at approximately $5.5 billion and expected to grow by 10% annually.
Interest in Collagen Technology
Continuous demand and interest from a wide range of companies in accessing CollPlant's rhCollagen, leading to potential future collaboration partnerships.
Showcase at International Society for Biofabrication
CollPlant presented its technology platform for mass production of human collagen and biofabrication of regenerative breast implants, gaining wide interest and opening new collaboration opportunities.
---
CLGN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
CLGN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 27, 2024 | $4.26 | $4.25 | -0.23% |
| Aug 20, 2024 | $4.90 | $4.85 | -1.02% |
| May 29, 2024 | $5.95 | $5.67 | -4.71% |
| Apr 04, 2024 | $5.46 | $5.26 | -3.66% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Collplant Holdings (CLGN) report earnings?
Collplant Holdings (CLGN) is schdueled to report earning on Apr 02, 2025, TBA Not Confirmed.
What is Collplant Holdings (CLGN) earnings time?
Collplant Holdings (CLGN) earnings time is at Apr 02, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is CLGN EPS forecast?
CLGN EPS forecast for the fiscal quarter 2024 (Q4) is -$0.13.
---